The Acute and Chronic Myelogenous Leukemia Partnering 2009-2014 report provides understanding and access to the acute and chronic myelogenous leukemia partnering deals and agreements entered into by the worlds leading healthcare companies. Read the full story

Pharmacyclics is a biopharmaceutical company founded in April 1991 discovering and developing medications to treat and alleviate the suffering of oncology patients. Read the full story

Headquartered in Dublin, Ireland Jazz Pharmaceuticals is a specialty biopharmaceuticals company that has undergone significant growth in recent years. Jazz Pharmaceuticals is focused upon delivering products for cataplexy, narcolepsy, oncology/leukemia, chronic pain and non-opioid schizophrenia.   Read the full story

Cellectis has signed a pharma partnering collaboration agreement with Servier to develop and commercialize novel product candidates targeting leukemia and solid tumors for $150 million. Read the full story

Royalty Pharma has sold it's $485 million interest in Ibrutinib to Aisling Capital and Clarus Ventures in a royalty financing round. Read the full story

Spectrum Pharmaceuticals entered M&A deals to acquire Talon Therapeutics and expects to complete the acquisition within one day. Read the full story

Life science deals financing has raised $32.5 million in the final closing of a private placement of common stock and warrants to purchase common stock for Celator. Read the full story

The Leukemia Partnering provides understanding and access to the leukemia partnering deals and agreements entered into by the worlds leading healthcare companies Read the full story